Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients

William Hankey, Michael A. McIlhatton, Kenechi Ebede, Brian Kennedy, Baris Hancioglu, Jie Zhang, Guy N. Brock, Kun Huang, Joanna Groden

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

APC biallelic loss-of-function mutations are the most prevalent genetic changes in colorectal tumors, but it is unknown whether these mutations phenocopy gain-of-function mutations in the CTNNB1 gene encoding b-catenin that also activate canonical WNT signaling. Here we demonstrate that these two mutational mechanisms are not equivalent. Furthermore, we show how differences in gene expression produced by these different mechanisms can stratify outcomes in more advanced human colorectal cancers. Gene expression profiling in Apc-mutant and Ctnnb1-mutant mouse colon adenomas identified candidate genes for subsequent evaluation of human TCGA (The Cancer Genome Atlas) data for colorectal cancer outcomes. Transcriptional patterns exhibited evidence of activated canonical Wnt signaling in both types of adenomas, with Apc-mutant adenomas also exhibiting unique changes in pathways related to proliferation, cytoskeletal organization, and apoptosis. Apc-mutant adenomas were characterized by increased expression of the glial nexin Serpine2, the human ortholog, which was increased in advanced human colorectal tumors. Our results support the hypothesis that APC-mutant colorectal tumors are transcription-ally distinct from APC-wild-type colorectal tumors with canonical WNT signaling activated by other mechanisms, with possible implications for stratification and prognosis. Significance: These findings suggest that colon adenomas driven by APC mutations are distinct from those driven by WNT gain-of-function mutations, with implications for identifying at-risk patients with advanced disease based on gene expression patterns.

Original languageEnglish (US)
Pages (from-to)617-630
Number of pages14
JournalCancer Research
Volume78
Issue number3
DOIs
StatePublished - Feb 1 2018

Fingerprint

Colorectal Neoplasms
Adenoma
Mutation
Colon
Gene Expression
Catenins
Atlases
Gene Expression Profiling
Neuroglia
Genes
Genome
Apoptosis
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients. / Hankey, William; McIlhatton, Michael A.; Ebede, Kenechi; Kennedy, Brian; Hancioglu, Baris; Zhang, Jie; Brock, Guy N.; Huang, Kun; Groden, Joanna.

In: Cancer Research, Vol. 78, No. 3, 01.02.2018, p. 617-630.

Research output: Contribution to journalArticle

Hankey, W, McIlhatton, MA, Ebede, K, Kennedy, B, Hancioglu, B, Zhang, J, Brock, GN, Huang, K & Groden, J 2018, 'Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients', Cancer Research, vol. 78, no. 3, pp. 617-630. https://doi.org/10.1158/0008-5472.CAN-17-1357
Hankey, William ; McIlhatton, Michael A. ; Ebede, Kenechi ; Kennedy, Brian ; Hancioglu, Baris ; Zhang, Jie ; Brock, Guy N. ; Huang, Kun ; Groden, Joanna. / Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients. In: Cancer Research. 2018 ; Vol. 78, No. 3. pp. 617-630.
@article{3ea8c3f9a2204f2db587c9c53b3c8c30,
title = "Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients",
abstract = "APC biallelic loss-of-function mutations are the most prevalent genetic changes in colorectal tumors, but it is unknown whether these mutations phenocopy gain-of-function mutations in the CTNNB1 gene encoding b-catenin that also activate canonical WNT signaling. Here we demonstrate that these two mutational mechanisms are not equivalent. Furthermore, we show how differences in gene expression produced by these different mechanisms can stratify outcomes in more advanced human colorectal cancers. Gene expression profiling in Apc-mutant and Ctnnb1-mutant mouse colon adenomas identified candidate genes for subsequent evaluation of human TCGA (The Cancer Genome Atlas) data for colorectal cancer outcomes. Transcriptional patterns exhibited evidence of activated canonical Wnt signaling in both types of adenomas, with Apc-mutant adenomas also exhibiting unique changes in pathways related to proliferation, cytoskeletal organization, and apoptosis. Apc-mutant adenomas were characterized by increased expression of the glial nexin Serpine2, the human ortholog, which was increased in advanced human colorectal tumors. Our results support the hypothesis that APC-mutant colorectal tumors are transcription-ally distinct from APC-wild-type colorectal tumors with canonical WNT signaling activated by other mechanisms, with possible implications for stratification and prognosis. Significance: These findings suggest that colon adenomas driven by APC mutations are distinct from those driven by WNT gain-of-function mutations, with implications for identifying at-risk patients with advanced disease based on gene expression patterns.",
author = "William Hankey and McIlhatton, {Michael A.} and Kenechi Ebede and Brian Kennedy and Baris Hancioglu and Jie Zhang and Brock, {Guy N.} and Kun Huang and Joanna Groden",
year = "2018",
month = "2",
day = "1",
doi = "10.1158/0008-5472.CAN-17-1357",
language = "English (US)",
volume = "78",
pages = "617--630",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Mutational mechanisms that activate wnt signaling and predict outcomes in colorectal cancer patients

AU - Hankey, William

AU - McIlhatton, Michael A.

AU - Ebede, Kenechi

AU - Kennedy, Brian

AU - Hancioglu, Baris

AU - Zhang, Jie

AU - Brock, Guy N.

AU - Huang, Kun

AU - Groden, Joanna

PY - 2018/2/1

Y1 - 2018/2/1

N2 - APC biallelic loss-of-function mutations are the most prevalent genetic changes in colorectal tumors, but it is unknown whether these mutations phenocopy gain-of-function mutations in the CTNNB1 gene encoding b-catenin that also activate canonical WNT signaling. Here we demonstrate that these two mutational mechanisms are not equivalent. Furthermore, we show how differences in gene expression produced by these different mechanisms can stratify outcomes in more advanced human colorectal cancers. Gene expression profiling in Apc-mutant and Ctnnb1-mutant mouse colon adenomas identified candidate genes for subsequent evaluation of human TCGA (The Cancer Genome Atlas) data for colorectal cancer outcomes. Transcriptional patterns exhibited evidence of activated canonical Wnt signaling in both types of adenomas, with Apc-mutant adenomas also exhibiting unique changes in pathways related to proliferation, cytoskeletal organization, and apoptosis. Apc-mutant adenomas were characterized by increased expression of the glial nexin Serpine2, the human ortholog, which was increased in advanced human colorectal tumors. Our results support the hypothesis that APC-mutant colorectal tumors are transcription-ally distinct from APC-wild-type colorectal tumors with canonical WNT signaling activated by other mechanisms, with possible implications for stratification and prognosis. Significance: These findings suggest that colon adenomas driven by APC mutations are distinct from those driven by WNT gain-of-function mutations, with implications for identifying at-risk patients with advanced disease based on gene expression patterns.

AB - APC biallelic loss-of-function mutations are the most prevalent genetic changes in colorectal tumors, but it is unknown whether these mutations phenocopy gain-of-function mutations in the CTNNB1 gene encoding b-catenin that also activate canonical WNT signaling. Here we demonstrate that these two mutational mechanisms are not equivalent. Furthermore, we show how differences in gene expression produced by these different mechanisms can stratify outcomes in more advanced human colorectal cancers. Gene expression profiling in Apc-mutant and Ctnnb1-mutant mouse colon adenomas identified candidate genes for subsequent evaluation of human TCGA (The Cancer Genome Atlas) data for colorectal cancer outcomes. Transcriptional patterns exhibited evidence of activated canonical Wnt signaling in both types of adenomas, with Apc-mutant adenomas also exhibiting unique changes in pathways related to proliferation, cytoskeletal organization, and apoptosis. Apc-mutant adenomas were characterized by increased expression of the glial nexin Serpine2, the human ortholog, which was increased in advanced human colorectal tumors. Our results support the hypothesis that APC-mutant colorectal tumors are transcription-ally distinct from APC-wild-type colorectal tumors with canonical WNT signaling activated by other mechanisms, with possible implications for stratification and prognosis. Significance: These findings suggest that colon adenomas driven by APC mutations are distinct from those driven by WNT gain-of-function mutations, with implications for identifying at-risk patients with advanced disease based on gene expression patterns.

UR - http://www.scopus.com/inward/record.url?scp=85041465733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041465733&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-1357

DO - 10.1158/0008-5472.CAN-17-1357

M3 - Article

C2 - 29212857

AN - SCOPUS:85041465733

VL - 78

SP - 617

EP - 630

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 3

ER -